Benzamide, 4-amino-5-chloro-2-methoxy-N-[(3S,4R)-3-methoxy-4-piperidinyl]-, hydrochloride CAS:221180-26-3

Benzamide, 4-amino-5-chloro-2-methoxy-N-[(3S,4R)-3-methoxy-4-piperidinyl]-, hydrochloride

Chemical Name: Benzamide, 4-amino-5-chloro-2-methoxy-N-[(3S,4R)-3-methoxy-4-piperidinyl]-, hydrochloride
CAS.NO: 221180-26-3
Synonyms:
4-AMINO-5-CHLORO-2-METHOXY-N-(3-METHOXYPIPERIDIN-4-YL)BENZAMIDE

Molecular Formula:C14H21Cl2N3O3
Molecular Weight:350.24100

Physical and Chemical Properties:
Density: /
Boiling point: /
Melting point:276-278 ° C (dec.)
Flash point:/
Refractive index: /

Specification:
Appearance:solid
Purity:≥98%

 

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Cisapride monophydrate  CAS:260779-88-2
Intermediates of Cisapride  CAS:81098-60-4



We are professional Benzamide, 4-amino-5-chloro-2-methoxy-N-[(3S,4R)-3-methoxy-4-piperidinyl]-, hydrochloride manufacturer and 4-AMINO-5-CHLORO-2-METHOXY-N-(3-METHOXYPIPERIDIN-4-YL)BENZAMIDE supplier in China, We offer quality 4-AMINO-5-CHLORO-2-METHOXY-N-(3-METHOXYPIPERIDIN-4-YL)BENZAMIDE you can fully trust, also we have India factory and producer of 4-AMINO-5-CHLORO-2-METHOXY-N-(3-METHOXYPIPERIDIN-4-YL)BENZAMIDE,Pls send inquiry of 4-AMINO-5-CHLORO-2-METHOXY-N-(3-METHOXYPIPERIDIN-4-YL)BENZAMIDE CAS:221180-26-3 to info@nbinno.com if you have any interests, thank you!


Related News: ICIG companies currently employ more than 3,000 people and operate 15 manufacturing facilities in Europe and the United States.1-(2-Methoxyphenyl)piperazine hydrochloride We manufacture APIs and drug manufacturers make medicines from APIs.N-(4-chloro-2,5-dimethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.Ethyl 2-bromopropionate CAS:535-11-5 CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.